Annual Operating Profit
$196.99 M
+$89.49 M+83.25%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual operaing income is currently $196.99 million, with the most recent change of +$89.49 million (+83.25%) on 31 December 2023. During the last 3 years, it has risen by +$186.03 million (+1698.31%). AMPH annual operating profit is now at all-time high.AMPH Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$57.05 M
+$1.83 M+3.32%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly operating income is currently $57.05 million, with the most recent change of +$1.83 million (+3.32%) on 30 September 2024. Over the past year, it has dropped by -$15.63 million (-21.51%). AMPH quarterly operating profit is now -21.51% below its all-time high of $72.68 million, reached on 30 September 2023.AMPH Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$214.25 M
-$15.63 M-6.80%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM operating income is currently $214.25 million, with the most recent change of -$15.63 million (-6.80%) on 30 September 2024. Over the past year, it has increased by +$33.42 million (+18.48%). AMPH TTM operating profit is now -6.80% below its all-time high of $229.88 million, reached on 30 June 2024.AMPH TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +83.3% | -21.5% | +18.5% |
| 3 y3 years | +1698.3% | +130.3% | +341.6% |
| 5 y5 years | +2384.4% | +2273.0% | +10000.0% |
AMPH Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1698.3% | -21.5% | +163.9% | -6.8% | +341.6% |
| 5 y | 5 years | at high | +2384.4% | -21.5% | +2052.4% | -6.8% | >+9999.0% |
| alltime | all time | at high | +688.4% | -21.5% | +660.1% | -6.8% | +756.5% |
Amphastar Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $57.05 M(+3.3%) | $214.25 M(-6.8%) |
| June 2024 | - | $55.22 M(+15.0%) | $229.88 M(+8.7%) |
| Mar 2024 | - | $48.01 M(-11.1%) | $211.56 M(+7.4%) |
| Dec 2023 | $196.99 M(+83.2%) | $53.98 M(-25.7%) | $196.99 M(+8.9%) |
| Sept 2023 | - | $72.68 M(+97.0%) | $180.84 M(+37.6%) |
| June 2023 | - | $36.90 M(+10.4%) | $131.39 M(+10.1%) |
| Mar 2023 | - | $33.43 M(-11.6%) | $119.32 M(+11.0%) |
| Dec 2022 | $107.50 M(+53.8%) | $37.83 M(+62.9%) | $107.50 M(+14.5%) |
| Sept 2022 | - | $23.23 M(-6.4%) | $93.92 M(-1.6%) |
| June 2022 | - | $24.82 M(+14.8%) | $95.46 M(+17.6%) |
| Mar 2022 | - | $21.61 M(-10.9%) | $81.19 M(+16.2%) |
| Dec 2021 | $69.89 M(+538.0%) | $24.25 M(-2.1%) | $69.89 M(+44.1%) |
| Sept 2021 | - | $24.77 M(+134.6%) | $48.51 M(+78.0%) |
| June 2021 | - | $10.56 M(+2.5%) | $27.26 M(+97.8%) |
| Mar 2021 | - | $10.31 M(+258.0%) | $13.78 M(+25.8%) |
| Dec 2020 | $10.95 M(<-9900.0%) | $2.88 M(-18.1%) | $10.95 M(+39.9%) |
| Sept 2020 | - | $3.52 M(-220.4%) | $7.83 M(+16.6%) |
| June 2020 | - | -$2.92 M(-139.1%) | $6.72 M(-36.7%) |
| Mar 2020 | - | $7.48 M(-3165.6%) | $10.61 M(<-9900.0%) |
| Dec 2019 | -$39.00 K(-99.5%) | -$244.00 K(-110.1%) | -$39.00 K(-102.2%) |
| Sept 2019 | - | $2.40 M(+147.1%) | $1.75 M(-7.7%) |
| June 2019 | - | $973.00 K(-130.7%) | $1.90 M(-194.0%) |
| Mar 2019 | - | -$3.17 M(-305.3%) | -$2.02 M(-76.6%) |
| Dec 2018 | -$8.62 M | $1.54 M(-39.4%) | -$8.62 M(-27.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $2.55 M(-186.7%) | -$11.91 M(-31.6%) |
| June 2018 | - | -$2.94 M(-69.9%) | -$17.41 M(+41.7%) |
| Mar 2018 | - | -$9.78 M(+460.0%) | -$12.28 M(+228.1%) |
| Dec 2017 | -$3.91 M(-125.4%) | -$1.75 M(-40.7%) | -$3.74 M(-45.1%) |
| Sept 2017 | - | -$2.94 M(-234.7%) | -$6.82 M(-455.9%) |
| June 2017 | - | $2.19 M(-276.4%) | $1.92 M(-80.9%) |
| Mar 2017 | - | -$1.24 M(-74.3%) | $10.06 M(-34.6%) |
| Dec 2016 | $15.38 M(-322.9%) | -$4.83 M(-183.2%) | $15.38 M(-55.4%) |
| Sept 2016 | - | $5.80 M(-43.9%) | $34.49 M(+38.2%) |
| June 2016 | - | $10.33 M(+153.5%) | $24.95 M(+462.3%) |
| Mar 2016 | - | $4.08 M(-71.5%) | $4.44 M(-164.3%) |
| Dec 2015 | -$6.90 M(-61.6%) | $14.29 M(-481.8%) | -$6.90 M(-75.9%) |
| Sept 2015 | - | -$3.74 M(-63.2%) | -$28.58 M(-12.4%) |
| June 2015 | - | -$10.19 M(+40.3%) | -$32.64 M(+39.2%) |
| Mar 2015 | - | -$7.26 M(-1.7%) | -$23.44 M(+30.3%) |
| Dec 2014 | -$17.98 M(-202.1%) | -$7.38 M(-5.4%) | -$17.98 M(+138.3%) |
| Sept 2014 | - | -$7.80 M(+689.9%) | -$7.55 M(-1643.4%) |
| June 2014 | - | -$988.00 K(-45.3%) | $489.00 K(-96.4%) |
| Mar 2014 | - | -$1.80 M(-159.2%) | $13.46 M(-23.6%) |
| Dec 2013 | $17.62 M(-35.9%) | $3.05 M(+1214.7%) | $17.62 M(+20.9%) |
| Sept 2013 | - | $232.00 K(-98.1%) | $14.57 M(+1.6%) |
| June 2013 | - | $11.98 M(+409.4%) | $14.33 M(+509.4%) |
| Mar 2013 | - | $2.35 M | $2.35 M |
| Dec 2012 | $27.49 M(-182.1%) | - | - |
| Dec 2011 | -$33.48 M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual operating profit year-on-year change?
- What is Amphastar Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly operating profit year-on-year change?
- What is Amphastar Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM operating profit year-on-year change?
What is Amphastar Pharmaceuticals annual operaing income?
The current annual operating profit of AMPH is $196.99 M
What is the all time high annual operating profit for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual operaing income is $196.99 M
What is Amphastar Pharmaceuticals annual operating profit year-on-year change?
Over the past year, AMPH annual operaing income has changed by +$89.49 M (+83.25%)
What is Amphastar Pharmaceuticals quarterly operating income?
The current quarterly operating profit of AMPH is $57.05 M
What is the all time high quarterly operating profit for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly operating income is $72.68 M
What is Amphastar Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, AMPH quarterly operating income has changed by -$15.63 M (-21.51%)
What is Amphastar Pharmaceuticals TTM operating income?
The current TTM operating profit of AMPH is $214.25 M
What is the all time high TTM operating profit for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM operating income is $229.88 M
What is Amphastar Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, AMPH TTM operating income has changed by +$33.42 M (+18.48%)